Do Anti-Depressants Work for People with TBI? BrainLine

Multimedia

• 
  Produced by Victoria Tilney McDonough and Brian King. Dr. Tedd Judd shares his experience and advice about culture, ethnicity, and brain injury rehab. Transcript of this video.
• Dr. Tedd Judd Talks About Understanding Behavior Changes with TBI
• 
  Dr. Maria Mouratidis is is a licensed neuropsychologist and currently the command consultant and subject matter expert for Traumatic Brain Injury and Psychological Health at the National Naval Medical Center. This is BrainLine's exclusive interview with Dr. Mouratidis recorded on September 17th, 2008. Transcript of the video here.
• Dr. Maria Mouratidis Talks About Differences in Expressing Emotion After Injury
• 
  Healthy Minds is a 13-part award-winning TV series about the latest research and insights about mental illness, created to help reduce the stigma associated with psychiatric disease, which often prevents patients and their families from getting needed help. This 30-minute segment on depression features veteran newsman Mike Wallace and his wife Mary, who discuss how they dealt with his depression and reveal intimate details about his suicide attempt and ultimate recovery. From WLIW21 Public Television, in conjunction with NARSAD. Used with permission. All rights reserved. Third-party use restricted. www.wliw.org. Transcript of this Video.
• Depression with Mike Wallace

More Information

• Neuroanatomy of Behavior After Brain Injury (pdf)

A brief summary of current research.

A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury

Ashman TA, Cantor JB, Gordon WA, Spielman L, Flanagan S, Ginsberg A, Engmann C, Egan M, Ambrose F, Greenwald B. Archives of Physical Medicine and Rehabilitation - May 2009 (Vol. 90, Issue 5, Pages 733-740)

People with TBI who had a diagnosis of major depression were treated either with sertraline, i.e. Zoloft, or a placebo for 10 weeks. Both groups showed improvements on measurements of mood, anxiety, and quality of life, with 59 percent of the group who took sertraline and 32 percent of the placebo group responding to the treatment.

Find out more.

 Comments

There are currently no comments for this article